Lymphadenopathy CT

Lymphadenopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Lymphadenopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT scan
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Lymphadenopathy CT On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Lymphadenopathy CT All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Lymphadenopathy CT
CDC on Lymphadenopathy CT
Lymphadenopathy CT in the news
Blogs on Lymphadenopathy CT
Directions to Hospitals Treating Lymphadenopathy
Risk calculators and risk factors for Lymphadenopathy CT

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

CT

Indications for CT include:

• Lymphoma

• Internal malignancies - for supraclavicular lymphadenopathy in malignancies of stomach, pancreas,

• Metastasis

• Sarcoidosis

• Pancoast tumor

CT scan of the chest showing lymphadenopathy in the mediastinum due to sarcoidosis.

References

Template:WH Template:WS